Yıl: 2023 Cilt: 8 Sayı: 2 Sayfa Aralığı: 325 - 333 Metin Dili: İngilizce DOI: 10.5336/healthsci.2022-91806 İndeks Tarihi: 31-05-2023

Cancer Incidence and Survival in Sivas Province 2013-2019: A Retrospective Cohort Study

Öz:
Objective: This study’s aim was to examine the inci- dence and survival of cancer in Sivas between 2013-2019. Material and Methods: In this retrospective cohort study, cancer registry data were analysed. Age, sex, treatment types, definitive pathological diag- nosis results, and survival status of patients were questioned. Results: A total of 7,946 people were diagnosed with cancer in the years exam- ined and 57.5% of the patients were male. Systemically the most com- mon type of cancer was digestive organ cancers (20.2%) (stomach, colon, anorectal, respectively). The most common cancers in male were prostate (16%), skin (14%), and bronchopulmonary (12%). The most common cancers in female were breast (22%), thyroid (16%), and skin (14%). The cancer incidence was between 1.4 per thousand and 2.3 per thousand. Life expectancy was shorter (p<0.001), and the mortality risk was 1.6 times higher in male. The risk of cancer mortality increased with increasing age. Respiratory system and intrathoracic organ can- cers were the cancers that caused the death and shortened the life span most (p<0.001). Conclusion: It was found that the cancer incidence tended to increase, and that the cancer mortality was higher in male and respiratory system organ cancers. It is important to keep detailed records (especially by including the stage and treatment protocols) in the follow-up of cancer cases.
Anahtar Kelime:

Sivas İli 2013-2019 Yılları Kanser İnsidansı ve Sağkalımı: Retrospektif Kohort Çalışması

Öz:
Amaç: Bu çalışmanın amacı, 2013-2019 yılları arasında Sivas ilinde kanser insidansını ve sağkalımını incelemektir. Gereç ve Yön- temler: Bu retrospektif kohort çalışmasında kanser kayıt verileri ince- lendi. Kanser hastalar ının ya ş, cinsiyet, ald ığı tedavi türleri, kesin patolojik tanı sonuçları ve sağkalım durumu sorgulandı. Bulgular: İn- celenen yıllarda toplam 7.946 ki şi kanser tan ısı almıştı ve hastaların %57,5’i erkekti. En çok görülen kanser tipi sindirim organları kanser- leriydi (%20,2) (sırasıyla mide, kolon, anorektal). Erkeklerde en sık gö- rülen kanserler prostat (%16), deri (%14) ve bronkopulmoner (%12) kanserdi. Kad ınlarda en s ık görülen kanserler meme (%22), tiroid (%16) ve deri (%14) kanseriydi. Kanser insidansı binde 1,4 ile binde 2,3 arasındaydı. Erkeklerde yaşam süresi daha kısaydı (p<0,001) ve mor- talite riski 1,6 kat fazlaydı. Yaş ilerledikçe kanser mortalite riski arttı. Ölüme en fazla neden olan ve yaşam süresini en fazla kısaltan kanser, solunum sistemi ve intratorasik organ kanserleriydi (p<0,001).Sonuç: Kanser insidansının artış eğiliminde olduğu ve kanser mortalitesinin erkeklerde ve solunum sistemi organ ı kanserlerinde daha yüksek ol- duğu saptandı. Kanser vakalarının takibinde, kayıtların (özellikle evre ve tedavi protokolleri dahil edilerek) ayr ıntılı olarak tutulmas ı çok önemlidir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. American Cancer Society. Cancer facts & figures 2019. Atlanta: American Cancer Society; 2019. [Cited: January 18, 2022]. Available from: [Link]
  • 2. World Health Organization [Internet]. [Cited: January 18, 2022]. Global Health Observatory. Geneva: World Health Organization. 2018. Available from: [Link]
  • 3. World Cancer Report 2014. Geneva, Switzerland: World Health Organiza- tion, International Agency for Research on Cancer. WHO Press; 2015. [Cited: January 18, 2022]. Available from: [Link]
  • 4. World Health Organization Globocan. Cancer fact sheets, all cancers. 2020. [Cited: January 18, 2022]. Available from: [Link]
  • 5. Singh GK, Jemal A. Socioeconomic and racial/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950-2014: over six decades of changing patterns and widening inequalities. J Environ Public Health. 2017;2017:2819372. [Crossref] [PubMed] [PMC]
  • 6. Singh GK, Siahpush M, Altekruse Sf. Time trends in liver cancer mortality, in- cidence, and risk factors by unemployment level and race/ethnicity, United States, 1969-2011. J Community Health. 2013;38(5):926-40. [Crossref] [PubMed]
  • 7. Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for U.S. adults: national health interview survey, 2012. vital Health Stat 10. 2014;(260):1-161. [PubMed]
  • 8. Singh GK, Williams SD, Siahpush M, Mulhollen A. Socioeconomic, rural- urban, and racial inequalities in US cancer mortality: Part I-all cancers and lung cancer and Part II-colorectal, prostate, breast, and cervical cancers. J Cancer Epidemiol. 2011;2011:107497. [Crossref] [PubMed] [PMC]
  • 9. Singh G, Miller B, Hankey B, Edwards B. Area socioeconomic variations in U.S. Cancer Incidence, Mortality, Stage, Treatment, and Survival, 1975-1999. NCI Cancer. Bethesda, MD: National Cancer Institute: NIH Publication No. 03- 5417; 2003. [Link]
  • 10. World Health Organization Globocan. Population fact sheets, countries, Turkey. 2020. [Cited: May 11, 2022]. Available from: [Link]
  • 11. Haydaroğlu A, Sert f, Caner A. Ege Üniversitesi Hastanesi veri tabanındaki kanser olgularının epidemiyolojik ve genel sa ğ kalım özellikleri [Epidemio- logical and overall survival characteristics o f cancer patients in Ege Univer- sity Hospital database]. Ege J Med. 2019;58(Supplement):1-9. [Crossref]
  • 12. Mete B, Söyiler v, Buzgan B. Cancer incidence and survival analysis among elderly people in Bingol province. Cukurova Med J. 2020;45(1):290-7.[Cross- ref]
  • 13. Çelikgün S, Koç T, Tuncer E, Özer H, Nur N. Cancer map between 2010- 2019 Sivas City. Int J Acad Med Pharm. 2021;3(3):273-6. [Crossref]
  • 14. Arıca S, Nazlıcan E, Özer C, Şilfeler DB, Arıca v, Özgür T, et al. Hatay ilinde 2008 yılı kanser vakaları sıklığı ve dağılımı [The frequency and disribution of cancer cases in Hatay District in 2008]. J Clin Exp Investig. 2011;2(2):192-5. [Crossref]
  • 15. Taşdemir E, Demir C, Dilek İ, Atmaca M. van ili ve çevresinde malign tümör- lerin dağılım sıklığı [The frequency o f the Malignant Tumors in " van" City and Around]. van Tıp Derg. 2010;17(4):117. [Link]
  • 16. Dong M, Cioffi G, Wang J, Waite KA, Ostrom QT, Kruchko C, et al. Sex di f- ferences in cancer incidence and survival: a pan-cancer analysis. Cancer Epidemiol Biomarkers Prev. 2020;29(7):1389-97. [Crossref] [PubMed]
  • 17. National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, fagerstrom RM, et al. Reduced lung-cancer mor- tality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395-409. [Crossref] [PubMed] [PMC]
  • 18. National Cancer Institute (NIH) [Internet]. [Cited: May 21, 2022]. The Sur- veillance, Epidemiology, and End Results (SEER) Program 2019. Available from: [Link]
  • 19. Lee JH, Wu HG, Kim HJ, Kim DW, Lee SH, Kim TM, et al. In fluence of co- morbidities on the e fficacy of radiotherapy with or without chemotherapy in elderly stage III non-small cell lung cancer patients. Cancer Res Treat. 2012;44(4):242-50. [Crossref] [PubMed] [PMC]
  • 20. Bill-Axelson A, Holmberg L, Ruutu M, Garmo H, Stark JR, Busch C, et al; SPCG-4 Investigators. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2011;364(18):1708-17. [Crossref] [PubMed]
  • 21. Mery CM, Pappas AN, Bueno R, Colson YL, Linden P, Sugarbaker DJ, et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemi- ology, and end results database. Chest. 2005 Jul;128(1):237-45. [Crossref] [PubMed]
APA AKOVA İ (2023). Cancer Incidence and Survival in Sivas Province 2013-2019: A Retrospective Cohort Study. , 325 - 333. 10.5336/healthsci.2022-91806
Chicago AKOVA İREM Cancer Incidence and Survival in Sivas Province 2013-2019: A Retrospective Cohort Study. (2023): 325 - 333. 10.5336/healthsci.2022-91806
MLA AKOVA İREM Cancer Incidence and Survival in Sivas Province 2013-2019: A Retrospective Cohort Study. , 2023, ss.325 - 333. 10.5336/healthsci.2022-91806
AMA AKOVA İ Cancer Incidence and Survival in Sivas Province 2013-2019: A Retrospective Cohort Study. . 2023; 325 - 333. 10.5336/healthsci.2022-91806
Vancouver AKOVA İ Cancer Incidence and Survival in Sivas Province 2013-2019: A Retrospective Cohort Study. . 2023; 325 - 333. 10.5336/healthsci.2022-91806
IEEE AKOVA İ "Cancer Incidence and Survival in Sivas Province 2013-2019: A Retrospective Cohort Study." , ss.325 - 333, 2023. 10.5336/healthsci.2022-91806
ISNAD AKOVA, İREM. "Cancer Incidence and Survival in Sivas Province 2013-2019: A Retrospective Cohort Study". (2023), 325-333. https://doi.org/10.5336/healthsci.2022-91806
APA AKOVA İ (2023). Cancer Incidence and Survival in Sivas Province 2013-2019: A Retrospective Cohort Study. Türkiye Klinikleri Sağlık Bilimleri Dergisi, 8(2), 325 - 333. 10.5336/healthsci.2022-91806
Chicago AKOVA İREM Cancer Incidence and Survival in Sivas Province 2013-2019: A Retrospective Cohort Study. Türkiye Klinikleri Sağlık Bilimleri Dergisi 8, no.2 (2023): 325 - 333. 10.5336/healthsci.2022-91806
MLA AKOVA İREM Cancer Incidence and Survival in Sivas Province 2013-2019: A Retrospective Cohort Study. Türkiye Klinikleri Sağlık Bilimleri Dergisi, vol.8, no.2, 2023, ss.325 - 333. 10.5336/healthsci.2022-91806
AMA AKOVA İ Cancer Incidence and Survival in Sivas Province 2013-2019: A Retrospective Cohort Study. Türkiye Klinikleri Sağlık Bilimleri Dergisi. 2023; 8(2): 325 - 333. 10.5336/healthsci.2022-91806
Vancouver AKOVA İ Cancer Incidence and Survival in Sivas Province 2013-2019: A Retrospective Cohort Study. Türkiye Klinikleri Sağlık Bilimleri Dergisi. 2023; 8(2): 325 - 333. 10.5336/healthsci.2022-91806
IEEE AKOVA İ "Cancer Incidence and Survival in Sivas Province 2013-2019: A Retrospective Cohort Study." Türkiye Klinikleri Sağlık Bilimleri Dergisi, 8, ss.325 - 333, 2023. 10.5336/healthsci.2022-91806
ISNAD AKOVA, İREM. "Cancer Incidence and Survival in Sivas Province 2013-2019: A Retrospective Cohort Study". Türkiye Klinikleri Sağlık Bilimleri Dergisi 8/2 (2023), 325-333. https://doi.org/10.5336/healthsci.2022-91806